表紙
市場調査レポート

世界の使い捨てバイオリアクター市場:製品タイプ別(組み換えタンパク、モノクローナル抗体)・細胞タイプ別(細菌、酵母)・技術別(攪拌SUB、使い捨て気泡塔バイオリアクター)・エンドユーザー別(生物薬剤メーカー)の予測

Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type (Bacteria, Yeast), Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019

発行 MarketsandMarkets 商品コード 318616
出版日 ページ情報 英文 157 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.95円で換算しております。
Back to Top
世界の使い捨てバイオリアクター市場:製品タイプ別(組み換えタンパク、モノクローナル抗体)・細胞タイプ別(細菌、酵母)・技術別(攪拌SUB、使い捨て気泡塔バイオリアクター)・エンドユーザー別(生物薬剤メーカー)の予測 Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type (Bacteria, Yeast), Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019
出版日: 2014年11月03日 ページ情報: 英文 157 Pages
概要

世界の使い捨てバイオリアクター(生物反応器)市場は、2014年における2億250万米ドルの規模から、CAGR(複合年間成長率)18.4%の伸びで、2019年には4億7,090万米ドルの規模に達する見込みとなっています。この市場の成長を促す主な要因としては、施設設立に際して必要とされる設備投資の少なさ、自動化における複雑さの緩和、およびエネルギー効率などが挙げられます。その一方で、混合プロセスに関する規制上の懸念、漏出物や抽出物による汚染、および適正製造基準(GMP)への対応の困難さが、市場の成長を阻害する要因となっています。

当レポートでは、世界の使い捨てバイオリアクター市場を取り上げ、市場の概要、市場発展促進・阻害要因、市場における課題および機会を概括し、製品タイプ別(組み換えタンパク、モノクローナル抗体)・細胞タイプ別(細菌、酵母)・技術別(攪拌SUB、使い捨て気泡塔バイオリアクター)・エンドユーザー別(生物薬剤メーカー)・地域別に市場の現状と見通しについて調査分析するとともに、競合環境、主要企業のプロファイルをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 プレミアムインサイト

第5章 市場概要

  • イントロダクション
  • 市場区分
    • 使い捨てバイオリアクター(SUB)市場、技術別
    • SUB市場、分子タイプ別
    • SUB市場、細胞タイプ別
    • SUB市場、エンドユーザー別
  • 市場動態
    • 市場発展促進要因
      • 小規模企業および新興企業にとっての投資利益率の向上
      • 自動化における複雑さの緩和
      • 海洋生物(藻類)培養の簡易性
      • 環境に対するプラスの影響
    • 市場発展阻害要因
      • 使い捨てバイオリアクターに関連した規制の懸念
      • 漏出物および抽出物に関する問題
      • GMP基準への対応の困難さ
    • 課題
      • 柔軟なバイオリアクターにおける制約
      • 使い捨てセンサーの機能向上のニーズ
    • 市場機会
      • 生物製剤市場の成長
    • 成功のための必須条件
      • 新たな動向としての生物薬剤企業におけるSUBの人気の高まり
    • 緊急の課題
      • 使い捨てシステムから従来型ステンレス鋼リードへと移行する際の生体分子の安定性がSUBの限定的導入につながる

第6章 産業の洞察

  • 産業の洞察
  • サプライチェーン分析
    • 主なインフルエンサー(影響者)
  • ポーターのファイブフォース分析
  • PESTLE分析
  • 産業の洞察

第7章 使い捨てバイオリアクター市場、技術別

  • イントロダクション
  • 波誘発動使い捨てバイオリアクター
  • 攪拌槽使い捨てバイオリアクター
  • 使い捨て気泡塔バイオリアクター
  • その他の技術

第8章 使い捨てバイオリアクター市場、分子タイプ別

  • イントロダクション
  • モノクローナル抗体(Mab)
  • ワクチン
  • 組み換えタンパク
  • 幹細胞
  • 遺伝子治療
  • その他(成長因子、インターフェロン、アンチセンス、RNA干渉)

第9章 使い捨てバイオリアクター市場、細胞タイプ別

  • イントロダクション
  • 哺乳類細胞
  • 細菌性細胞
  • 酵母細胞
  • その他(昆虫細胞、植物細胞)

第10章 使い捨てバイオリアクター市場、エンドユーザー別

  • イントロダクション
  • 研究開発部門
  • 生物薬剤メーカー

第11章 使い捨てバイオリアクター市場、地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • その他欧州
  • アジア太平洋(APAC)
  • その他地域(ROW)

第12章 競合情勢

  • 概要
  • 市場シェア分析、世界の使い捨てバイオリアクター市場
  • 新製品発表
  • 合意、パートナーシップ
  • 買収
  • 事業拡張
  • その他の動き

第13章 企業プロファイル(業績、製品・サービス、主な戦略、最近の動き、等)

  • イントロダクション
  • Applikon Biotechnology
  • Cellexus Limited
  • Cellution Biotech
  • Ge Healthcare(General Electric Companyの子会社)
  • Merck Kgaa
  • Pall Corporation
  • Parker Hannifin Corporation
  • Pbs Biotech, Inc.
  • Sartorius Ag
  • Thermo Fisher Scientific, Inc.

第14章 付録

  • 業界専門家の洞察
  • ディスカッションガイド
  • Rtの紹介:リアルタイム市場情報
  • 可能なカスタマイゼーション
  • 関連レポート

図表

目次
Product Code: BT 2863

Developing markets such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations.

The report segments the global SUB market by molecule type, type of cell, technology, end user, and region. The monoclonal antibodies (MAbs) segment accounted for the lion's share of the global SUB market, by molecule type. However, the stem cell segment is expected to grow at the highest CAGR in the forecast period, owing to an increased focus on research in this segment.

On the basis of type of cell, the SUB market is categorized into mammalian cell, bacterial cell, yeast cell and others (insect cell and plant cell). The mammalian cell segment is expected to be the new revenue pocket in the market by type of cell. Increasing numbers of biologics are being based on mammalian cells due to their increased compatibility and bioactivity in humans.

The technology segment is subsegmented into wave-induced motion SUBs, stirred SUBs, single-use bubble column bioreactors and others (single-use reactors with vertically perforated discs and single-use hybrid reactors). Wave-induced motion SUB technology is the oldest and most widely accepted of these, which accounts for its large market share.

Research and development (R&D) of biopharmaceutical manufacturers, research institutes and contract research organizations (CROs) are the major end users of the SUB, followed by biopharmaceutical manufacturing. The large share of the R&D segment can be attributed to the wide acceptance of SUBs for small- and mid-scale biopharmaceutical manufacturing for clinical testing and R&D.

New and innovative product launches were found to be the dominant strategy adopted by key industry participants to increase their market share and cater to unmet market needs.

From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis, such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and related growth of various segments in the industry. It also focuses on emerging and high-growth segments of the SUB market, high-growth regions, and the initiatives of respective governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the SUB market and their product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Table of Contents

1. Introduction

  • 1.1. Objectives Of The Study
  • 1.2. Market Definition
  • 1.3. Market Scope
    • 1.3.1. Limitation Of The Study
    • 1.3.2. Markets Covered
  • 1.4. Stakeholders
  • 1.5. Years Considered In The Study
  • 1.6. Currency

2. Research Methodology

  • 2.1. Market Size Estimation
  • 2.2. Market Crackdown And Data Triangulation
    • 2.2.1. Key Data From Secondary Sources
    • 2.2.2. Key Data From Primary Sources
      • 2.2.2.1. Key Industry Insights
    • 2.2.3. Assumptions

3. Executive Summary

4. Premium Insights

  • 4.1. Attractive Market Opportunities In The Market
  • 4.2. Single Use Bioreactor Market, By Molecule Type
  • 4.3. Market Snapshot
  • 4.4. SUB Market, By Technology
  • 4.5. SUB Market, By End User
  • 4.6. Lifecycle Analysis, By Region
  • 4.7. Asia-Pacific To Show Quickest Growth

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Segmentation
    • 5.2.1. Single-Use Bioreactor Market, By Technology
    • 5.2.2. SUB Market, By Type Of Molecule
    • 5.2.3. SUB Market, By Type Of Cells
    • 5.2.4. SUB Market, By End User
  • 5.3. Market Dynamics
    • 5.3.1. Improved Returns On Investment For Small Companies And Startups
    • 5.3.2. Reduced Complexity Of Automation
    • 5.3.3. Ease In Cultivation Of Marine Organisms (Algae)
    • 5.3.4. Positive Impact On The Environment
  • 5.4. Restraints
    • 5.4.1. Regulatory Concerns Related To Single-Use Bioreactor
    • 5.4.2. Issues Regarding Leachables And Extractables
    • 5.4.3. Difficulties In Meeting The Gmp Standards
  • 5.5. Challenges
    • 5.5.1. Limitations In Flexible Bioreactors
    • 5.5.2. Need For Improved Single-Use Sensors
  • 5.6. Opportunities
    • 5.6.1. Growing Biologics Market
  • 5.7. Winning Imperatives
    • 5.7.1. Growing Popularity Of Subs Among Biopharmaceutical Companies Is An Evolving Trend
  • 5.8. Burning Issues
    • 5.8.1. Stability Of Biomolecules While Shifting From Single-Use Systems To Traditional Stainless Steel Leads To Limited Adoption Of Subs

6. Industry Insights

  • 6.1. Industry Insights
  • 6.2. Supply Chain Analysis
    • 6.2.1. Key Influencers
  • 6.3. Porter's Five Forces Analysis
    • 6.3.1. Threat From New Entrants
    • 6.3.2. Threat From Substitutes
    • 6.3.3. Bargaining Power Of Suppliers
    • 6.3.4. Bargaining Power Of Buyers
    • 6.3.5. Intensity Of Competitive Rivalry
  • 6.4. Pestle Analysis
    • 6.4.1. Political Factors
    • 6.4.2. Economic Factors
    • 6.4.3. Social Factors
    • 6.4.4. Technological Factors
    • 6.4.5. Environmental Factors
    • 6.4.6. Legal Factors
  • 6.5. Industry Insights

7. Single Use Bioreactor Market, By Technology

  • 7.1. Introduction
  • 7.2. Wave-Induced Motion Single-Use Bioreactors
  • 7.3. Stirred Tank Single-Use Bioreactors
  • 7.4. Single-Use Bubble Column Bioreactors
  • 7.5. Other Technologies

8. Single Use Bioreactor Market, By Molecule Type

  • 8.1. Introduction
  • 8.2. Monoclonal Antibodies (Mabs)
  • 8.3. Vaccines
  • 8.4. Recombinant Proteins
  • 8.5. Stem Cells
  • 8.6. Gene Therapy
  • 8.7. Others (Growth Factors, Interferons, Antisense, And Rna Interference)

9. Single Use Bioreactor Market, By Type Of Cell

  • 9.1. Introduction
  • 9.2. Mammalian Cells
  • 9.3. Bacterial Cells
  • 9.4. Yeast Cells
  • 9.5. Others (Insect Cells And Plant Cells)

10. Single Use Bioreactor Market, By End User

  • 10.1. Introduction
  • 10.2. R&D Departments
  • 10.3. Biopharmaceutical Manufacturers

11. Single Use Bioreactor Market, By Geography

  • 11.1. Introduction
  • 11.2. North America
    • 11.2.1. U.S.
    • 11.2.2. Canada
  • 11.3. Europe
    • 11.3.1. Germany
    • 11.3.2. U.K.
    • 11.3.3. Rest Of Europe (Roe)
  • 11.4. Asia-Pacific (Apac)
  • 11.5. Rest Of The World (Row)

12. Competitive Landscape

  • 12.1. Overview
  • 12.2. Market Share Analysis, Global Single-Use Bioreactor Market
  • 12.3. New Product Launches
  • 12.4. Agreements & Partnerships
  • 12.5. Acquisitions
  • 12.6. Expansions
  • 12.7. Other Developments

13. Company Profiles

  • 13.1. Introduction
  • 13.2. Applikon Biotechnology
  • 13.3. Cellexus Limited
  • 13.4. Cellution Biotech
  • 13.5. Ge Healthcare (Subsidiary Of General Electric Company)
  • 13.6. Merck Kgaa
  • 13.7. Pall Corporation
  • 13.8. Parker Hannifin Corporation
  • 13.9. Pbs Biotech, Inc.
  • 13.10. Sartorius Ag
  • 13.11. Thermo Fisher Scientific, Inc.

*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

14. Appendix

  • 14.1. Insights Of Industry Experts
  • 14.2. Discussion Guide
  • 14.3. Introducing Rt: Real-Time Market Intelligence
  • 14.4. Available Customizations
  • 14.5. Related Reports

List of Tables

  • Table 1: Single-Use Bioreactors Market Size, By Technology, 2012-2019 ($Million)
  • Table 2: Wave-Induced Motion Single-Use Bioreactors Market Size, By Region, 2012-2019 ($Million)
  • Table 3: Stirred Tank Single-Use Bioreactors Market Size, By Region, 2012-2019 ($Million)
  • Table 4: Single-Use Bubble Column Bioreactors Market Size, By Region, 2012-2019 ($Million)
  • Table 5: Single-Use Bioreactors Other Technologies Market Size, By Region, 2012-2019 ($Million)
  • Table 6: Market Size, By Molecule Type, 2012-2019 ($Million)
  • Table 7: Single-Use Bioreactors Monoclonal Antibodies Market Size, By Region, 2012-2019 ($Million)
  • Table 8: North America: SUB Monoclonal Antibodies Market Size, By Country, 2012-2019 ($Million)
  • Table 9: Europe: SUB Monoclonal Antibodies Market Size, By Country, 2012-2019 ($Million)
  • Table 10: Single-Use Bioreactors Vaccines Market Size, By Region, 2012-2019 ($Million)
  • Table 11: North America: SUB Vaccines Market Size, By Country, 2012-2019 ($Million)
  • Table 12: Europe: SUB Vaccines Market Size, By Country, 2012-2019 ($Million)
  • Table 13: Single-Use Bioreactors Recombinant Proteins Market Size, By Region, 2012-2019 ($Million)
  • Table 14: North America: Single-Use Bioreactors Recombinant Proteins Market Size, By Country, 2012-2019 ($Million)
  • Table 15: Europe: Single-Use Bioreactors Recombinant Proteins Market Size, By Country, 2012-2019 ($Million)
  • Table 16: Single-Use Bioreactors Stem Cells Market Size, By Region, 2012-2019 ($Million)
  • Table 17: North America: Single Use Bioreactor Stem Cells Market Size, By Country, 2012-2019 ($Million)
  • Table 18: Europe: Single Use Bioreactor Stem Cells Market Size, By Country, 2012-2019 ($Million)
  • Table 19: Single Use Bioreactor Gene Therapy Market Size, By Region, 2012-2019 ($Million)
  • Table 20: North America: Single Use Bioreactor Gene Therapy Market Size, By Country, 2012-2019 ($Million)
  • Table 21: Europe: Single Use Bioreactor Gene Therapy Market Size, By Country, 2012-2019 ($Million)
  • Table 22: Single Use Bioreactor Other Molecules Market Size, By Region, 2012-2019 ($Million)
  • Table 23: North America: Single Use Bioreactors Other Molecules Market Size, By Country, 2012-2019 ($Million)
  • Table 24: Europe: Single Use Bioreactor Other Molecules Market Size, By Country, 2012-2019 ($Million)
  • Table 25: Single Use Bioreactor Market Size, By Type Of Cell, 2012-2019 ($Million)
  • Table 26: Single Use Bioreactor Market Size For Mammalian Cells, By Region, 2012-2019 ($Million)
  • Table 27: North America: Market Size For Mammalian Cells, By Country, 2012-2019 ($Million)
  • Table 28: Europe: Market Size For Mammalian Cells, By Country, 2012-2019 ($Million)
  • Table 29: Single-Use Bioreactors Market Size For Bacterial Cells, By Region, 2012-2019 ($Million)
  • Table 30: North America: Market Size For Bacterial Cells, By Country, 2012-2019 ($Million)
  • Table 31: Europe: Market Size For Bacterial Cells, By Country, 2012-2019 ($Million)
  • Table 32: Europe Will Continue To Lead Single Use Bioreactor Market For Yeast Cells
  • Table 33: Single Use Bioreactor Market Size For Yeast Cells, By Region, 2012-2019 ($Million)
  • Table 34: North America: Market Size For Yeast Cells, By Country, 2012-2019 ($Million)
  • Table 35: Europe: Market Size For Yeast Cells, By Country, 2012-2019 ($Million)
  • Table 36: Single Use Bioreactor Market Size For Other Cells, By Region, 2012-2019 ($Million)
  • Table 37: North America: Market Size For Other Cells, By Country, 2012-2019 ($Million)
  • Table 38: Europe: Market Size For Other Cells, By Country, 2012-2019 ($Million)
  • Table 39: Market Size, By End User, 2012-2019 ($Million)
  • Table 40: Single-Use Bioreactors R&D Departments Market Size, By Region, 2012-2019 ($Million)
  • Table 41: North America: Single-Use Bioreactors R&D Departments Market Size, By Country, 2012-2019 ($Million)
  • Table 42: Europe: Single-Use Bioreactors R&D Departments Market Size, By Country, 2012-2019 ($Million)
  • Table 43: Single-Use Bioreactors Biopharmaceutical Manufacturers Market Size, By Region, 2012-2019 ($Million)
  • Table 44: North America: SUB Biopharmaceutical Manufacturers Market Size, By Country, 2012-2019 ($Million)
  • Table 45: Europe: SUB Biopharmaceutical Manufacturers Market Size, By Country, 2012-2019 ($Million)
  • Table 46: Single Use Bioreactor Market Size, By Region, 2012-2019 ($Million)
  • Table 47: North America: Market Size, By Country, 2012-2019 ($Million)
  • Table 48: North America: Market Size, By Molecule Type, 2012-2019 ($Million)
  • Table 49: North America: Market Size, By Type Of Cell, 2012-2019 ($Million)
  • Table 50: North America: Market Size, By Technology, 2012-2019 ($Million)
  • Table 51: North America: Market Size, By End User, 2012-2019 ($Million)
  • Table 52: U.S.: Market Size, By Molecule Type, 2012-2019 ($Million)
  • Table 53: U.S.: Market Size, By Type Of Cell, 2012-2019 ($Million)
  • Table 54: U.S.: Market Size, By End User, 2012-2019 ($Million)
  • Table 55: Canada: Market Size, By Molecule Type, 2012-2019 ($Million)
  • Table 56: Canada: Market Size, By Type Of Cell, 2012-2019 ($Million)
  • Table 57: Canada: Market Size, By End User, 2012-2019 ($Million)
  • Table 58: Europe: Market Size, By Country, 2012-2019 ($Million)
  • Table 59: Europe: Market Size, By Molecule Type, 2012-2019 ($Million)
  • Table 60: Europe: Market Size, By Type Of Cell, 2012-2019 ($Million)
  • Table 61: Europe: Market Size, By Technology, 2012-2019 ($Million)
  • Table 62: Europe: Market Size, By End User, 2012-2019 ($Million)
  • Table 63: Germany: Market Size, By Molecule Type, 2012-2019 ($Million)
  • Table 64: Germany: Market Size, By Type Of Cell, 2012-2019 ($Million)
  • Table 65: Germany: Market Size, By End User, 2012-2019 ($Million)
  • Table 66: U.K.: Market Size, By Molecule Type, 2012-2019 ($Million)
  • Table 67: U.K.: Market Size, By Type Of Cell, 2012-2019 ($Million)
  • Table 68: U.K.: Market Size, By End User, 2012-2019 ($Million)
  • Table 69: Roe: Market Size, By Molecule Type, 2012-2019 ($Million)
  • Table 70: Roe: Market Size, By Type Of Cell, 2012-2019 ($Million)
  • Table 71: Roe: Market Size, By End User, 2012-2019 ($Million)
  • Table 72: Other Asia-Pacific Countries And Drivers For Market
  • Table 73: Apac: Market Size, By Molecule Type, 2012-2019 ($Million)
  • Table 74: Apac: Market Size, By Type Of Cell, 2012-2019 ($Million)
  • Table 75: Apac: Market Size, By Technology, 2012-2019 ($Million)
  • Table 76: Apac: Market Size, By End User, 2012-2019 ($Million)
  • Table 77: Row: Market Size, By Molecule Type, 2012-2019 ($Million)
  • Table 78: Row: Market Size, By Type Of Cell, 2012-2019 ($Million)
  • Table 79: Row: Market Size, By Technology, 2012-2019 ($Million)
  • Table 80: Row: Market Size, By End User, 2012-2019 ($Million)
  • Table 81: New Product Launches, 2011-2014
  • Table 82: Agreements & Partnerships, 2011-2014
  • Table 83: Acquisition, 2011-2014
  • Table 84: Expansion, 2011-2014
  • Table 85: Other Developments, 2011-2014

List of Figures

  • Figure 1: Research Methodology
  • Figure 2: Market Size Estimation
  • Figure 3: Breakdown Of Primary Interviews: By Type, Company, Designation, And Region
  • Figure 4: Market Snapshot, By Type Of Cells (2014 Vs. 2019)
  • Figure 5: SUB Market, By Molecule Type
  • Figure 6: SUB Market, By Technology
  • Figure 7: SUB Market, By End User
  • Figure 8: Geographical Snapshot, 2014
  • Figure 9: Growing Biologics Market And Improved Return On Investment Will Drive Market Growth
  • Figure 10: Monoclonal Antibodies Segment To Hold Largest Market Share
  • Figure 11: North America Continues To Hold Maximum Market Share Of SUB Market
  • Figure 12: Wave-Induced Motion Bioreactor Segment Continues To Lead Sub Technology Market
  • Figure 13: Biopharmaceutical Manufacturers End-User Segment To See Highest Growth Rate From 2014-2019
  • Figure 14: Asia-Pacific Market Holds Lucrative Growth Opportunities
  • Figure 15: Asia-Pacific Will Grow At Fastest Rate In 2014-2019
  • Figure 16: Evolution
  • Figure 17: Technological Advancements Play A Crucial Role In The SUB Market
  • Figure 18: Single Use Bioreactor Market, By Technology
  • Figure 19: Market, By Type Of Molecule
  • Figure 20: Market, By Type Of Cells
  • Figure 21: Market, By End User
  • Figure 22: Improved Returns On Investment Will Spur The Growth Of The SUB Market
  • Figure 23: Supply Chain: Absence Of Guidelines Imposes Additional Burden On Sub Manufacturers
  • Figure 24: Porter's Five Forces Analysis
  • Figure 25: Europe To Hold Largest Share Of Wave-Induced Motion Market In Forecast Period
  • Figure 26: Europe Continue To Lead The Stirred Tank Segment From 2014 To 2019
  • Figure 27: Europe To Dominate Single-Use Bubble Column Bioreactors Market In Forecast Period
  • Figure 28: North America To Account For Second-Largest Share Of The Other Technologies Segment In 2019
  • Figure 29: Monoclonal Antibodies Segment Dominates The Single-Use Bioreactors Market, By Molecule Type
  • Figure 30: Europe Will Dominate The Recombinant Proteins Market
  • Figure 31: Asia-Pacific Expected To Show Fastest Growth In Forecast Period
  • Figure 32: Europe Dominates Gene Therapy Market
  • Figure 33: Asia-Pacific To Show Highest Growth In Other Molecules Market
  • Figure 34: Mammalian Cell Segment To Dominate The Single-Use Bioreactors Market, By Type Of Cell
  • Figure 35: Europe Will Continue To Lead The Market For Mammalian Cells In The Forecast Period
  • Figure 36: Bacterial Cells Segment To Emerge As Revenue Pocket For Manufacturers Of SUB In Asia-Pacific
  • Figure 37: Europe: Single-Use Bioreactors Market For Other Cells, By Country, 2012-2019 ($Million)
  • Figure 38: Broad End-User Base Of SUB Market
  • Figure 39: R&D (Cros, Biopharmaceutical Manufacturers, And Research Institutes) Segment Dominates The SUB End-User Market
  • Figure 40: Europe Will Continue To Lead The Market
  • Figure 41: Europe Will Continue To Lead The Biopharmaceutical Manufacturers End-User Market
  • Figure 42: Geographic Snapshot (2014): High-Growth Markets Emerging As New Revenue Pockets
  • Figure 43: Asia-Pacific: Attractive Market For All Molecule Types For Single Use Bioreactor
  • Figure 44: North America Market Snapshot: Government Support And Funding To Drive Demand For Single Use Bioreactor
  • Figure 45: Europe Market Snapshot: U.K. Is The Major Segment In The European Single-Use Bioreactors Market
  • Figure 46: Apac Market Snapshot: Monoclonal Antibodies Segment To Account For Largest Share In Apac
  • Figure 47: Wave-Induced Motion Technology Segment To Witness The Highest Growth In Row
  • Figure 48: Product Innovation, And Agreements, Collaborations And Partnerships Were Key Strategies Adopted In Last Three Years
  • Figure 49: Global Single-Use Bioreactor Market Share, By Key Player, 2013
  • Figure 50: Battle For Market Share: New Product Launches And Agreements, Collaboration And Partnerships Were Key Strategies
  • Figure 51: Geographical Revenue Mix Of Top 5 Market Players
Back to Top